Investor Presentaiton

Flowchart of Approval of Type 1 Use Regulations in JAPAN (Clinical Research) Head of the Medical Institute intending to use Gene therapy product (genetically-modified virus) in Clinical Research Draft of "Type 1 Use Regulations" Application for Approval and "Biological Diversity Risk Assessment Report" Approval User The Use Complying with the Published Use Regulations The Minister of MHLW The Minister of the Environment Consultation with Experts Health Science Council Public Consultation Approved if No Adverse Effect on Biological Diversity Could Arise Formulation of Information on Correct Use (as needed) Publication of the Approved Use Regulations and Information on Correct Use

View entire presentation